from Breakingviews:

Cox: Two signs of M&A bacchanal’s last hurrah

By Rob Cox
December 1, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Pfizer’s war chest stealthily rebuilt by Allergan

November 25, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Delay in Pfizer split is material adverse event

November 24, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Pfizer-Allergan to throw down tax-reform gauntlet

November 23, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Heads won’t roll at Mylan despite blunders

November 13, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Valeant CEO gets called on $100 mln excess

November 6, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Bill Ackman pushes limits of activism at Valeant

November 5, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Shire pays up for easier prey than Baxalta

November 2, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own. 

from Breakingviews:

Merger Monday has a scary Halloween afterglow

November 2, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Ackman’s Valeant defense nervy but unpersuasive

October 30, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.